Advanced Embryology & ICSI

In Vitro Fertilization (IVF) Treatment & Cleanroom Embryology
Level 2 ART & ICMR Registered Centre
Class 10,000 Cleanroom Positive pressure VOC filtration ensures zero ambient embryotoxicity.
Benchtop Tri-Gas Incubators Rapid gas recovery mimicking physiological fallopian tube micro-environment.
-196°C Vitrification Ultra-rapid cryopreservation with >99% post-thaw blastocyst survival.
70–75% Cumulative Success
99%+ Vitrification Survival
Day 5–6 Blastocyst Culture
Book Consultation
GOLD STANDARD IN ASSISTED REPRODUCTION

World Class IVF Care Backed by Science, Guided by Compassion

In Vitro Fertilization (IVF) commonly known as the “test tube baby” procedure remains the gold standard of assisted reproductive technology for couples and individuals facing complex fertility challenges. Our IVF program combines advanced laboratory embryology, continuous monitoring, and individualized stimulation protocols to maximize each patient's realistic chance of a healthy pregnancy. Every treatment plan is designed around your specific diagnosis, history, and goals never a one-size-fits-all protocol.

What is IVF?

IVF involves retrieving mature eggs from the ovaries and fertilizing them with sperm inside a controlled laboratory environment. The resulting embryos are cultured and closely monitored for several days before the healthiest one(s) are transferred into the uterus. IVF can address a wide spectrum of fertility issues from tubal blockages to severe male-factor infertility and has helped countless people build the families they've hoped for.

STEP-BY-STEP OVERVIEW

What Happens in an IVF Cycle?

An IVF cycle involves gentle ovarian stimulation, precision ultrasound guided egg retrieval, controlled laboratory fertilization, and blastocyst transfer into the uterus for natural implantation.

Day 5–6
BLASTOCYST TRANSFER WINDOW

Optimal Transfer Stage

Extended culture to the Day 5–6 blastocyst stage ensures that only embryos demonstrating peak cellular vitality and highest implantation potential are selected for transfer.

DYNAMIC CLINICAL ANALYTICS

Interactive Clinical Graph & Predictive Outcomes

Explore real-time data models for age prognosis, blastocyst culturing, and frozen transfer protocols:

Live Interactive Model
Select Patient Age (Female): 29 Years
62% Pregnancy Rate
Per Blastocyst Transfer
Dr. Devkriti Cleanroom Lab (Blastocyst SET) 62% (Dr. Devkriti Centre)
Standard National Clinical Average 44% (National Avg)
Optimal Age Window (< 35 Years) Blastocyst Gold Standard

High ovarian reserve and peak oocyte chromosomal normalcy. Our Level-2 cleanroom lab utilizes Single Blastocyst Transfer (SET) to achieve over 60%+ clinical pregnancy while eliminating high-order multi-pregnancy risks.

Cumulative Clinical Pregnancy Potential (Sequential Cycles) With Vitrified Blastocysts
1st Cycle Transfer
58–65%

Single fresh or frozen blastocyst transfer

2nd Cycle (Cumulative)
78%

Subsequent frozen embryo transfer (FET)

3rd Cycle (Cumulative)
88%+

Maximal cumulative biological probability

Implantation Rate
58%
Day 5 Blastocyst

vs 32% for Day 3 embryo (+81% relative increase in uterine attachment)

Live Birth Rate
65%
Per Blastocyst Transfer

Extended benchtop incubation selects embryos with highest chromosomal vitality

Multiple Pregnancy Risk
< 1.5%
Single Embryo (SET)

vs 24% high-risk multiples in unselected Day-3 double embryo transfer

Day 5–6 Blastocyst Transfer (Single SET) 65% Clinical Pregnancy
Conventional Day 3 Cleavage Embryo 42% Clinical Pregnancy
Why Day 5–6 Blastocyst Transfer Is Our Clinic Standard

Between Day 3 and Day 5, an embryo must activate its own embryonic genome. Embryos with fatal chromosomal abnormalities arrest naturally during this transition. By extending culture to the blastocyst stage in individual benchtop tri-gas chambers, Dr. Devkriti transfers only self-validated, prime embryos — maximizing singleton live births while avoiding maternal-fetal risks of multi-gestation.

Endometrial Receptivity
78%
Frozen Cycle (FET)

Uterine lining is prepared under natural physiological hormone conditions

Pregnancy Rate Advantage
+17%
Higher In Vitrified FET

63% ongoing pregnancy in FET vs 46% in immediate fresh post-stimulation cycle

OHSS Complication Risk
0.0%
Freeze-All Strategy

Complete elimination of life-threatening Ovarian Hyperstimulation Syndrome

Frozen Embryo Transfer (Ultra-Rapid Vitrification) 63% Live Birth Potential
Immediate Fresh Embryo Transfer 46% Live Birth Potential
The Physiological Science Behind 'Freeze-All' (FET)

During the stimulation phase, super-ovulation medications temporarily cause supra-physiological estradiol levels, which can advance endometrial histology out of sync with the embryo. With ultra-rapid vitrification achieving >99% blastocyst survival, elective freezing gives the female body time to reset to baseline. Transferring into a calm, hormonally receptive endometrium significantly elevates implantation odds.

When Is IVF Recommended?

IVF is often the recommended path for those facing the following fertility challenges:

01
Blocked or Damaged Fallopian Tubes

IVF bypasses the tubes entirely, making it viable for tubal-factor infertility.

02
Male Factor Infertility

Low sperm count, poor motility, or abnormal morphology overcome via lab selection.

03
Ovulation Disorders

Including resistant PCOS or premature ovarian insufficiency.

04
Endometriosis

When endometrial tissue affects ovaries, tubes, or pelvic anatomy.

05
Unexplained Infertility

No identifiable cause after a comprehensive clinical fertility workup.

06
Previous Failed IUI

For couples who haven't achieved success with less invasive treatment options.

07
Genetic Disorders

To enable preimplantation genetic testing (PGT) and significantly reduce transmission risk.

The IVF Journey — Nine Guided Steps

A carefully coordinated journey bridging clinical expertise, lab precision, and constant patient support:

Consultation

An initial appointment (online or in-clinic) to review history and outline the treatment path.

01
02
Baseline Bloodwork & Ultrasound

Establishes reproductive health markers to tailor the most effective protocol.

Ovarian Stimulation

Medications stimulate the ovaries to develop multiple mature eggs.

03
04
Oocyte Maturation

Hormone treatment ensures eggs reach full maturity ahead of retrieval.

Egg Retrieval

A minor surgical procedure collects mature eggs for lab fertilization.

05
06
Fertilization (via ICSI)

A single sperm is injected into each mature egg; ~70% typically fertilize successfully.

Embryo Transfer

The healthiest embryo(s) are placed into the uterus for implantation.

07
08
Two-Week Wait

The waiting period between transfer and the confirmatory pregnancy test.

Pregnancy Test

Confirms whether implantation and early pregnancy have occurred.

09
EMBRYOLOGY MILESTONES

From Fertilization to Blastocyst: The 5-Day Embryo Journey

Click on any developmental stage to view clinical parameters observed inside our cleanroom incubators:

D0
D1
D2
D3
D5
Day 0: Oocyte Retrieval & ICSI Micro-Injection DAY 0
Oocyte Retrieval & ICSI

Mature Metaphase-II oocytes are denuded and micro injected with a morphologically normal sperm.

MII Oocyte Grade
Day 1: 2PN Fertilization Verification DAY 1
2PN Fertilization Check

At 16–18 hours post ICSI, two pronuclei (maternal & paternal) confirm true normal diploid fertilization.

Normal 2PN Stage
Day 2: 4-Cell Cleavage Embryo DAY 2
4-Cell Cleavage Stage

First cell divisions yield symmetric blastomeres with zero to minimal fragmentation in benchtop incubators.

Even Blastomeres
Day 3: 8-Cell Cleavage & Compaction DAY 3
8-Cell / Morula Stage

Rapid cellular mitotic division progresses into compaction as cells form tight junctional complexes.

Grade A / B Embryo
Day 5–6: Expanded Blastocyst Stage DAY 5–6
Expanded Blastocyst

Inner Cell Mass (future baby) and Trophectoderm (future placenta) with fluid cavity, ready for transfer.

Gardner 4AA / 5AA
IVF Laboratory and Procedure

Success Rates & Influencing Factors

IVF success varies across individual clinical profiles. Our tailored protocols optimize each parameter to maximize your cumulative probability of conception.

Clinical Benchmark Bands
50–70%
Age 35 Years
40–50%
Age 35–40 Years
20–40%
Age > 40 Years
25–35%
Average / Cycle
5 Key Factors Shaping IVF Outcomes
01
Age of the Woman

Younger patients generally see higher success rates due to higher follicular reserve and chromosomal stability.

02
Quality of Eggs and Sperm

Healthy gametes improve fertilization and embryo development odds into resilient blastocysts.

03
Underlying Fertility Issues

Certain conditions (severe endometriosis, adenomyosis, tubal hydro-salpinx) can influence outcome likelihood and require preparatory care.

04
Number of IVF Cycles

Cumulative success often increases across multiple attempts through protocol refinement and frozen transfers.

05
Lifestyle Factors

A balanced diet, weight optimization, stress moderation, and abstinence from smoking positively support IVF outcomes.

WHY CHOOSE OUR CENTRE

Why Choose Our Centre for IVF?

World-class embryology science delivered with warmth and German fellowship-trained clinical precision — designed around your highest realistic chance of taking home a healthy baby.

01
Fellowship Trained

Expertise & Experience

Led by Dr. Devkriti Tiwari Dhirawani with advanced German Fellowship training in Reproductive Medicine and minimally invasive laparoscopic precision.

12+ Yrs Clinical Focus ICMR Level-2 ART
02
Individualized Care

Personalized Treatment Plans

Every stimulation dosage, trigger timing, and frozen embryo transfer (FET) protocol is customized to your unique ovarian reserve, AMH, and hormonal profile.

Zero Assembly-Line Cycles DuoStim / Mild Protocols
03
Complete In-House

Comprehensive Services

From initial 3D scans and andrology diagnostic workups to advanced ICSI, blastocyst vitrification, and hysteroscopic correction completely under one roof.

No External Lab Travel Full In-House ART
04
Cleanroom Standard

State-of-the-Art Embryology Lab

Positive-pressure Class 10,000 cleanroom lab with multi-stage VOC filtration, individual benchtop tri-gas incubators mimicking physiological fallopian tubes, and laser micromanipulation.

Zero Ambient Embryotoxicity >99% Vitrification Survival Day 5 Blastocyst Culture
05
Transparent & Ethical

Patient-Centered Compassion

We honor the emotional courage of your family-building journey. Transparent clinical odds, clear treatment pricing without hidden surcharges, and empathetic support at every visit.

Strict Double Witnessing Direct Doctor Consultations 100% Patient Confidentiality
Registered Level-2 ART Centre (ICMR)
Class 10,000 Zero-VOC Cleanroom Lab
German Fellowship Clinical Protocol
55%–75% Cumulative Blastocyst Rate

Advanced Lab Technology at Dr. Devkriti Embryology & Laparoscopic Centre

Class 10,000 Cleanroom Lab

Zero-VOC certified positive pressure embryology lab with multi-stage HEPA filtration, ensuring an untainted embryonic environment.

Benchtop Tri-Gas Incubators

Individual incubation chambers with rapid gas and temperature recovery, mimicking the natural in-vivo environment of the human fallopian tube.

Vitrification Cryo Storage

99%+ post thaw survival rate with ultra-rapid vitrification protocols for blastocysts, oocytes, and sperm samples.

Level 2 ART Certified Centre

Strict double witnessing protocols, complete patient confidentiality, and fully registered ART Level 2 clinic credentials.

Frequently Asked Questions About IVF

No. The egg collection is performed under short intravenous sedation administered by our consultant anesthetist. You will be comfortably asleep during the 15-minute procedure and will not feel any pain. Most patients recover within 1–2 hours and can return home the same day.

Medical research conclusively demonstrates that prolonged bed rest does not improve Embryology success rates. In fact, gentle movement improves pelvic blood circulation. You may resume light routine daily activities the following day, avoiding only heavy lifting, rigorous workouts, and high stress.

In conventional IVF, thousands of sperm are placed in a dish with each egg, and the most robust sperm fertilizes the egg naturally. In ICSI (Intracytoplasmic Sperm Injection), an embryologist selects a single healthy sperm under a high-magnification inverted microscope and injects it directly into the egg. ICSI is particularly recommended for male factor infertility or low fertilization history.

Our clinical pregnancy rates range between 55% and 75% per transfer depending on female age, blastocyst quality, and endometrial receptivity. By combining Day 5 blastocyst transfers with frozen embryo transfer (FET) cycles, we consistently achieve outcomes on par with top national fertility benchmarks.

TREATMENT COMPARISON GUIDE

IVF vs IUI — Which Treatment Is Right for You?

Both IVF and IUI are proven assisted reproductive technologies, but they differ significantly in complexity, lab intervention, timeline, and realistic pregnancy probability. Understanding these medical distinctions empowers you to choose the most effective path alongside Dr. Devkriti.

VS
SIMPLER • FIRST-LINE OPTION

IUI (Intrauterine Insemination)

Specially washed and concentrated high motility sperm is placed directly inside the uterine cavity during natural or mildly induced ovulation. Fertilization occurs naturally inside the fallopian tubes.

10–20% Success / Cycle
15 Mins Procedure Time
Minimal Invasiveness
Most Effective When:
  • Mild male factor infertility (adequate motile sperm)
  • Young couples (< 35 yrs) with unexplained infertility
  • Mild ovulatory dysfunction responsive to oral medication
  • Cervical hostility or physical ejaculation challenges
Key Prerequisite: At least one fallopian tube must be healthy and open.
ADVANCED • HIGHEST SUCCESS

IVF (In Vitro Fertilization)

Eggs are retrieved from the ovaries, fertilized with selected sperm in our cleanroom lab, cultured to Day 5 blastocyst stage, and the healthiest embryo is transferred into the uterus. Full lab control over every critical milestone.

45–65%+ Success / Transfer
3–4 Weeks Cycle Window
Outpatient Mild Sedation
Most Effective When:
  • Blocked, severely damaged, or absent fallopian tubes
  • Moderate to severe male factor infertility (ICSI indicated)
  • Moderate to severe Endometriosis or Adenomyosis
  • 2–3 previous failed IUI attempts or low AMH ovarian reserve
Key Advantage: Completely bypasses fallopian tubes & enables blastocyst genetic testing (PGT).

IVF vs IUI — Comprehensive Clinical Comparison

Evidence-Based Parameters
Clinical Parameter IUI Treatment IVF Treatment (Advanced ART)
Fertilization Site Occurs in vivo naturally inside the woman's fallopian tubes. Occurs in vitro inside our Class 10,000 cleanroom lab; cultured to Day 5 blastocyst.
Laboratory Complexity Basic andrology sperm wash and concentration (~1 hour lab prep). High-precision micromanipulation, laser ICSI, and benchtop tri-gas incubation.
Fallopian Tube Status Mandatory At least one tube must be completely patent. Not Needed Bypasses tubes entirely.
Success Rate per Attempt 10% – 20% per cycle (female age dependent). 45% – 65%+ per blastocyst transfer (SET).
Cycle Timeline Single 15-minute outpatient procedure on ovulation day. 3 to 4 weeks (ovarian stimulation, retrieval, culturing, and embryo transfer).
Anesthesia Requirement None required painless, similar to a routine pelvic exam. Short 15-minute gentle IV sedation for egg collection (zero pain).
Male Factor Infertility Effective for mild motility or count challenges only. Overcomes severe male factor, poor morphology, and azoospermia (via ICSI/TESA).
Genetic Screening (PGT) Not possible (fertilization occurs inside the body). Fully compatible with Preimplantation Genetic Testing (PGT-A / PGT-M).
Cost & Financial Model Lower cost per cycle; recommended for 2–3 initial attempts. Higher initial investment; highest realistic cumulative pregnancy probability.

Which Treatment Is Clinically Recommended Based on Cause?

Triage Guidelines
Primary Clinical Diagnosis IUI Suitability IVF / ICSI Suitability
Blocked or Damaged Fallopian Tubes Not Feasible (Blocked Path) Gold Standard (Bypasses tubes)
Severe Male Factor / Low Motility / TESA Not Recommended Primary Choice (with ICSI)
Unexplained Infertility (Female < 35 Yrs) First-Line Choice (2–3 Cycles) Next Step if IUI Fails
Ovulation Disorders (Responsive PCOS) Recommended First-Line For Resistant PCOS / OHSS Risk
Moderate to Severe Endometriosis / DIE Limited (< 8–10% Success) Highly Recommended First Line
Low Ovarian Reserve (Low AMH / Age > 37) Delays Time-Sensitive Care Optimal (DuoStim + Cryopreservation)
3+ Previous Unsuccessful IUI Cycles Diminishing Biological Returns Definitive Next Treatment
Still Unsure Which Path Is Right for You?

No two fertility profiles are identical. A comprehensive fertility evaluation by Dr. Devkriti Tiwari Dhirawani reveals your precise egg reserve, sperm dynamics, and tubal patency allowing us to advise the gentlest, highest-probability treatment suited to your family goals.

AGE & Embryology outcomes

Embryology success rates by Age What to Expect

Age is the single most important factor influencing IVF success. It directly impacts egg quality, ovarian reserve, and the potential for a healthy pregnancy. Understanding age-related expectations helps you plan your treatment journey realistically.

Under
35
Under 35 Years

Highest egg quality and robust ovarian reserve. Excellent response to stimulation.

50–60%+ Success Rate per Cycle
35–37
35–37 Years

Gradual decline begins. Success remains favorable with tailored stimulation and embryo selection protocols.

40–50% Success Rate per Cycle
38–40
38–40 Years

More noticeable decline. Embryo screening (PGT-A) and DuoStim protocol may be discussed to optimize outcomes.

30–40% Success Rate per Cycle
Over
40
Over 40 Years

Increased challenges. Donor egg strategies may be recommended. Every case is individually assessed by Dr. Devkriti for the best approach.

<30% Success Rate per Cycle
Factors Beyond Age That Influence Success
  • Ovarian Reserve (AMH, AFC): Even at younger ages, low AMH can reduce response. DuoStim protocol can maximize egg collection.
  • Lifestyle Factors: Diet, healthy weight, reducing stress, and avoiding smoking all positively influence egg and sperm quality.
  • Underlying Conditions: PCOS, endometriosis, uterine anomalies, and thyroid imbalances impact receptivity — all addressed at our centre.
  • Sperm Health: Advanced sperm selection (ICSI, IMSI) helps even in challenging male factor cases.

Age should never be a reason to give up hope. Book a consultation with Dr. Devkriti for an individualized assessment and realistic success estimates based on your profile.